These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5853692)

  • 1. Side-chain degradation and ring hydroxylation of pehnothiazine tranquilizers.
    Fishman V; Goldenberg H
    J Pharmacol Exp Ther; 1965 Oct; 150(1):122-8. PubMed ID: 5853692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uptake of promazine, chlorpromazine, and their desmethyl-metabolites into the isolated perfused rat brain].
    Jähnchen E; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):300-9. PubMed ID: 4260499
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination by microcoulometric gas chromatography of chlorpromazine metabolites in human urine.
    Johnson DE; Rodriguez CF; Burchfield HP
    Biochem Pharmacol; 1965 Oct; 14(10):1453-69. PubMed ID: 5865871
    [No Abstract]   [Full Text] [Related]  

  • 4. [Uptake of phenothiazine derivatives by the isolated perfused rat brain].
    Krieglstein J; Jähnchen E
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):380-1. PubMed ID: 4253813
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of promazine and chlorpromazine metabolites on the cornea.
    Adams HR; Manian AA; Steenberg ML; Buckley JP
    Adv Biochem Psychopharmacol; 1974; 9(0):281-93. PubMed ID: 4836207
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotransformations in vitro undergone by phenothiazine derivatives in a liver preparation.
    Robinson AE
    J Pharm Pharmacol; 1966 Jan; 18(1):19-32. PubMed ID: 4380699
    [No Abstract]   [Full Text] [Related]  

  • 7. Accumulation of phenothiazine tranquilizers in rat brain and plasma after repeated dosage.
    Mahju MA; Maickel RP
    Biochem Pharmacol; 1969 Oct; 18(10):2701-10. PubMed ID: 5404004
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of the binding of drugs to albumin and erythrocytes in a perfusion medium for the isolated rat liver].
    Jähnchen E; Krieglstein J; Kunkel F; Samuelis WJ; Wollert U
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):67-84. PubMed ID: 4252444
    [No Abstract]   [Full Text] [Related]  

  • 9. Albumin binding and hydrophobic character of promazine and chlorpromazine metabolites.
    Kriegelstein J; Lier F; Michaelis J
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(2):121-30. PubMed ID: 4258285
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative distribution, excretion, and metabolism of 14C-labeled quaternary ammonium compounds of promazine, chlorpromazine, and triflupromazine.
    Huang CL; Yeh JZ; Muni IA
    J Pharm Sci; 1970 Aug; 59(8):1114-8. PubMed ID: 5457327
    [No Abstract]   [Full Text] [Related]  

  • 11. Model metabolites of chlorpromazine and promazine: relative activities in some pharmacological and behavioral tests.
    POSNER HS; HEARST E; TAYLOR WL; COSMIDES GJ
    J Pharmacol Exp Ther; 1962 Jul; 137():84-90. PubMed ID: 14488181
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydrophobic character of phenothiazine derivatives as determining factor for their initial uptake by the isolated perfused rat liver].
    Jähnchen E; Krieglstein J; Kunkel F; Samuelis WJ
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):363-4. PubMed ID: 4254339
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of chlorpromazine and promazine in vitro: isolation and characterization of N-oxidation products.
    Beckett AH; Navas GE; Hutt AJ
    Xenobiotica; 1988 Jan; 18(1):61-74. PubMed ID: 3354233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin-layer chromatography of chlorpromazine metabolites. Attempt to identify each of the metabolites appearing in blood, urine and feces of chronically medicated schizophrenics.
    Turano P; Turner WJ; Manian AA
    J Chromatogr; 1973 Jan; 75(2):277-93. PubMed ID: 4701542
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral and hepatic fixation of phenothiazine and iminodibenzyl derivatives in rats].
    Stephan Y; Welin L; Mainard F
    C R Acad Hebd Seances Acad Sci D; 1972 Sep; 275(10):1087-9. PubMed ID: 4629719
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the results of using the Forrests' test on mental patients treated with aminazine and propazine].
    Likhobabenko IuM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1701-6. PubMed ID: 6001062
    [No Abstract]   [Full Text] [Related]  

  • 17. A DETAILED EVALUATION OF PROMAZINE METABOLISM.
    GOLDENBERG H; FISHMAN V; HEATON A; BURNETT R
    Proc Soc Exp Biol Med; 1964 Apr; 115():1044-51. PubMed ID: 14166555
    [No Abstract]   [Full Text] [Related]  

  • 18. [Absolute bioavailability of chlorpromazine, promazine and promethazine].
    Koytchev R; Alken RG; Kirkov V; Neshev G; Vagaday M; Kunter U
    Arzneimittelforschung; 1994 Feb; 44(2):121-5. PubMed ID: 8147942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Labeling method in the study of the fate of two phenothiazine derivatives in the organism; S35-labeled aminazine and promazine].
    FEDOROV NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1958; 58(2):137-49. PubMed ID: 13605119
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultraviolet and attenuated total reflectance infrared spectra of chlorpromazine metabolites.
    Warren RJ; Thompson WE; Zarembo JE; Eisdorfer IB
    J Pharm Sci; 1967 Nov; 56(11):1496-500. PubMed ID: 6060595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.